Dr. Robert C. Farr, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Ste 236, Coeur D Alene, ID 83814 Phone: 208-765-1345 Fax: 208-667-9622 |
Dr. Daniel Edward Cannon, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 700 W Ironwood Dr Ste 278, Coeur D Alene, ID 83814 Phone: 208-625-5160 Fax: 208-625-5733 |
Dr. Ronald J Stout, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 700 W Ironwood Dr, Ste 236, Coeur D Alene, ID 83814 Phone: 208-765-1345 Fax: 208-667-9622 |
Dr. Ian M Smith, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 700 W Ironwood Dr, Suite 278, Coeur D Alene, ID 83814 Phone: 208-625-5160 Fax: 208-625-5733 |
News Archive
Postmortem analysis of the brains of ten professional athletes with chronic traumatic encephalopathy (CTE) provides new insights into the specific types of brain abnormalities associated with this diagnosis, reports a study in the July issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
"The recession is driving up enrollment in Medicaid at higher than expected rates, threatening gargantuan state budget gaps even as Congress and the White House seek to expand the government health insurance program for the poor and disabled," The New York Times reports.
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer.
Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.
Adoptive cell transfer is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients.
› Verified 8 days ago